Technology platform reproducibility – EATRIS Webinar series (5/6)
|Date & Time||January 21 2020, 15.00 -16.00 CET|
- Weida Tong (NCTR/FDA)
- Marian Hajduch (IMTM)
High-throughput technologies are revolutionising medical research moving towards integration of multi-omic information. In this context quality and reproducibility of data generated through different technology platforms is key.
The session will give the floor to 2 different technology platforms experts: genomic (Dr Weida Tong) and proteomic (Dr Marian Hajduch), highlighting the challenges, need and approaches in both technologies to ensure quality and robustness of the results generated.
An interactive Q&A session will conclude this 60-minute-webinar.
Reproducibility is a foundational element of the scientific method, a benchmark upon which the reliability of an experiment can be tested. However, the field is facing alarmingly high irreproducibility rates as illustrated in various industry publications, with reports ranging from 50% to 80% of published results not being reproducible. It has been estimated that in the US alone, $28B in funding is spent on preclinical research that is not reproducible. This estimation does not even consider the impact on delaying translational research and causing high failure rates observed for the development of new treatments.
In this context, EATRIS will run a series of webinars this fall, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). The aim is to bring best practices together and to discuss solutions designed to tackle the identified bottlenecks.
You will have the chance to get the latest updates from experts in the field as well as participate in a Q&A session at the end of the lecture. Please note that you will have the opportunity to watch again later as all webinars will be recorded.